135 related articles for article (PubMed ID: 20963812)
1. Comparison of in vitro micronucleus and gene mutation assay results for p53-competent versus p53-deficient human lymphoblastoid cells.
Honma M; Hayashi M
Environ Mol Mutagen; 2011 Jun; 52(5):373-84. PubMed ID: 20963812
[TBL] [Abstract][Full Text] [Related]
2. Relationship between p53 status and 5-fluorouracil sensitivity in 3 cell lines.
Oka H; Ikeda K; Yoshimura H; Ohuchida A; Honma M
Mutat Res; 2006 Jul; 606(1-2):52-60. PubMed ID: 16584912
[TBL] [Abstract][Full Text] [Related]
3. Involvement of p53 function in different magnitude of genotoxic and cytotoxic responses in in vitro micronucleus assays.
Hashimoto K; Nakajima Y; Uematsu R; Matsumura S; Chatani F
Mutat Res; 2011 Nov; 726(1):21-8. PubMed ID: 21855649
[TBL] [Abstract][Full Text] [Related]
4. Generation of loss of heterozygosity and its dependency on p53 status in human lymphoblastoid cells.
Honma M
Environ Mol Mutagen; 2005; 45(2-3):162-76. PubMed ID: 15688360
[TBL] [Abstract][Full Text] [Related]
5. Relationships between p53 status, apoptosis and induction of micronuclei in different human and mouse cell lines in vitro: Implications for improving existing assays.
Whitwell J; Smith R; Jenner K; Lyon H; Wood D; Clements J; Aschcroft-Hawley K; Gollapudi B; Kirkland D; Lorge E; Pfuhler S; Tanir JY; Thybaud V
Mutat Res Genet Toxicol Environ Mutagen; 2015 Aug; 789-790():7-27. PubMed ID: 26232254
[TBL] [Abstract][Full Text] [Related]
6. Difference in susceptibility to morphological changes in the nucleus to aneugens between p53-competent and p53-abrogated lymphoblastoid cell lines (TK6 and NH32 cells) in the in vitro micronucleus assay.
Hashimoto K; Nakajima Y; Uematsu R; Chatani F
Mutagenesis; 2012 May; 27(3):287-93. PubMed ID: 22042714
[TBL] [Abstract][Full Text] [Related]
7. Reduction of misleading ("false") positive results in mammalian cell genotoxicity assays. I. Choice of cell type.
Fowler P; Smith K; Young J; Jeffrey L; Kirkland D; Pfuhler S; Carmichael P
Mutat Res; 2012 Feb; 742(1-2):11-25. PubMed ID: 22138618
[TBL] [Abstract][Full Text] [Related]
8. Study of oxidative DNA damage in TK6 human lymphoblastoid cells by use of the thymidine kinase gene-mutation assay and the in vitro modified comet assay: determination of No-Observed-Genotoxic-Effect-Levels.
Platel A; Nesslany F; Gervais V; Claude N; Marzin D
Mutat Res; 2011 Dec; 726(2):151-9. PubMed ID: 21930235
[TBL] [Abstract][Full Text] [Related]
9. Comparison of four different treatment conditions of extended exposure in the in vitro micronucleus assay using TK6 lymphoblastoid cells.
Hashimoto K; Nakajima Y; Matsumura S; Chatani F
Regul Toxicol Pharmacol; 2011 Feb; 59(1):28-36. PubMed ID: 20800082
[TBL] [Abstract][Full Text] [Related]
10. Potassium bromate treatment predominantly causes large deletions, but not GC>TA transversion in human cells.
Luan Y; Suzuki T; Palanisamy R; Takashima Y; Sakamoto H; Sakuraba M; Koizumi T; Saito M; Matsufuji H; Yamagata K; Yamaguchi T; Hayashi M; Honma M
Mutat Res; 2007 Jun; 619(1-2):113-23. PubMed ID: 17428505
[TBL] [Abstract][Full Text] [Related]
11. Induction of TK mutations in human lymphoblastoid TK6 cells by the rat carcinogen 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX).
Hakulinen P; Yamamoto A; Koyama N; Kumita W; Yasui M; Honma M
Mutat Res; 2011 Oct; 725(1-2):43-9. PubMed ID: 21784170
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of TK gene mutation assay in TK6 and TK6-E6 cell induced by vinblastin and colcemid].
Wang YN; Shuai PQ; Ding XQ; Zhang LS
Wei Sheng Yan Jiu; 2006 Jul; 35(4):409-11. PubMed ID: 16986510
[TBL] [Abstract][Full Text] [Related]
13. Using CTLL-2 and CTLL-2 bcl2 cells to avoid interference by apoptosis in the in vitro micronucleus test.
Meintières S; Biola A; Pallardy M; Marzin D
Environ Mol Mutagen; 2003; 41(1):14-27. PubMed ID: 12552588
[TBL] [Abstract][Full Text] [Related]
14. Flow-cytometric analysis of in vitro micronucleus formation: comparative studies with WIL2-NS human lymphoblastoid and L5178Y mouse lymphoma cell lines.
Laingam S; Froscio SM; Humpage AR
Mutat Res; 2008 Oct; 656(1-2):19-26. PubMed ID: 18718554
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of loss of heterozygosity induced by vinblastine at tk locus in human lymphoblastoid cell line TK6].
Wang YN; Shuai PQ; Guo YJ; Zhang LS
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jul; 37(4):558-61. PubMed ID: 16909601
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic and mutagenic responses to X-rays and chemical mutagens in normal and p53-mutated human lymphoblastoid cells.
Honma M; Hayashi M; Sofuni T
Mutat Res; 1997 Mar; 374(1):89-98. PubMed ID: 9067419
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
Kirkland D; Aardema M; Henderson L; Müller L
Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
[TBL] [Abstract][Full Text] [Related]
18. Chromosome breakage induced by the genotoxic agents mitomycin C and cytosine arabinoside is concentration and p53 dependent.
Brüsehafer K; Rees BJ; Manshian BB; Doherty AT; O'Donovan MR; Doak SH; Jenkins GJ
Toxicol Sci; 2014 Jul; 140(1):94-102. PubMed ID: 24675086
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of an in vitro micronucleus assay platform in TK6 cells.
Sobol Z; Homiski ML; Dickinson DA; Spellman RA; Li D; Scott A; Cheung JR; Coffing SL; Munzner JB; Sanok KE; Gunther WC; Dobo KL; Schuler M
Mutat Res; 2012 Jul; 746(1):29-34. PubMed ID: 22445949
[TBL] [Abstract][Full Text] [Related]
20. An in vitro micronucleus assay with size-classified micronucleus counting to discriminate aneugens from clastogens.
Hashimoto K; Nakajima Y; Matsumura S; Chatani F
Toxicol In Vitro; 2010 Feb; 24(1):208-16. PubMed ID: 19747535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
